Zhejiang Jiuzhou Pharmaceutical Co Ltd banner
Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 17.02 CNY -2.13% Market Closed
Market Cap: ¥15.1B

Gross Margin

34.6%
Current
Improving
by 0.1%
vs 3-y average of 34.6%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
34.6%
=
Gross Profit
¥1.9B
/
Revenue
¥5.4B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
34.6%
=
Gross Profit
¥1.9B
/
Revenue
¥5.4B

Peer Comparison

Country Company Market Cap Gross
Margin
CN
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
15.1B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
875.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
563.9B USD
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.5B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
294.7B USD
Loading...
CH
Novartis AG
SIX:NOVN
228B CHF
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
156.7B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121.1B USD
Loading...

Market Distribution

Higher than 70% of companies in China
Percentile
70th
Based on 8 314 companies
70th percentile
34.6%
Low
-2 148% — 14.3%
Typical Range
14.3% — 34.6%
High
34.6% — 775.2%
Distribution Statistics
China
Min -2 148%
30th Percentile 14.3%
Median 23%
70th Percentile 34.6%
Max 775.2%

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Glance View

Market Cap
15.1B CNY
Industry
Pharmaceuticals

Founded in 1973, Zhejiang Jiuzhou Pharmaceutical Co. Ltd. has steadily navigated the evolving tides of the global pharmaceutical industry with a compelling blend of innovation and traditional business acumen. Rooted in China's dynamic Zhejiang province, the company initially focused on manufacturing basic pharmaceutical intermediates. Over the years, it strategically expanded its operations, becoming a key player in both the Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) sectors. This dual focus has allowed Jiuzhou Pharmaceutical to innovate and offer comprehensive services, ranging from drug development to commercial manufacturing, effectively appealing to a broad range of customers including some of the world's leading pharmaceutical companies. At the heart of Jiuzhou Pharmaceutical's success lies its commitment to research and development, a cornerstone that supports its diversification strategy. The company leverages its extensive expertise and cutting-edge technology to improve existing drugs while also participating in the development of new, patented pharmaceuticals. By fostering strong partnerships with global pharmaceutical giants, Jiuzhou effectively integrates itself into the larger pharmaceutical ecosystem, providing customized solutions that resonate with market demand. This business model not only reinforces its financial growth but also establishes Zhejiang Jiuzhou as an indispensable contributor to advancements in medicine, continually enhancing its reputation on the international stage.

Intrinsic Value
22.79 CNY
Undervaluation 25%
Intrinsic Value
Price ¥17.02
Z
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
34.6%
=
Gross Profit
¥1.9B
/
Revenue
¥5.4B
What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's current Gross Margin?

The current Gross Margin for Zhejiang Jiuzhou Pharmaceutical Co Ltd is 34.6%, which is above its 3-year median of 34.6%.

How has Gross Margin changed over time?

Over the last 3 years, Zhejiang Jiuzhou Pharmaceutical Co Ltd’s Gross Margin has increased from 34.4% to 34.6%. During this period, it reached a low of 30.9% on Dec 31, 2024 and a high of 37.6% on Sep 30, 2023.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett